株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

CountryFocus:ブラジルの医療・規制・医療費償還制度の状況

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

発行 GlobalData 商品コード 287369
出版日 ページ情報 英文 247 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.81円で換算しております。
Back to Top
CountryFocus:ブラジルの医療・規制・医療費償還制度の状況 CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil
出版日: 2015年07月13日 ページ情報: 英文 247 Pages
概要

ブラジルの医薬品市場は、2012年の238億米ドルから、2020年には588億米ドルまで、年平均(CAGR)12%で拡大すると予想されています。また医療機器の市場規模も、2012年の79億米ドルから、2020年には131億米ドルにまで拡大すると推計されています。市場拡大の主な要因として、高齢者人口の増大や、医療保険カバー率の上昇などが挙げられます。

当レポートでは、ブラジルの医療関連市場の動向や、医療費償還制度およびその他の関連規制・制度について分析し、医薬品産業・医療装置産業の全体的構造・動向、医療費償還制度やその周辺の保険市場の動向、医療規制当局の構造や各種規制の概要、ブラジル経済・社会に関するマクロ的指標(医療インフラなど)といった情報を取りまとめています。

第1章 目次

第2章 イントロダクション

第3章 医薬品・医療機器市場の概要

  • 医薬品市場
    • 市場概況
    • 医薬品の輸出入
    • 供給経路
    • 市場の分類
    • 主な疾患分野
    • 主要企業
  • 医療機器市場
    • 市場概況
    • 上位5分野の概況
    • 診断市場
    • 主要企業
  • 市場の促進・阻害要因
    • 促進要因
    • 阻害要因

第4章 市場へのアクセス

  • 医療制度の概要
    • 組織構造
  • 医療費償還・保険料支払者の状況
    • 医療費償還の過程
    • 薬価制定の手順
    • 保険業者の概要
    • 医療費支出に対する患者負担の比率
    • 処方薬の価格動向
    • 薬価政策
  • 規制環境
    • 規制機関の概要
    • 新薬の認証過程
    • ジェネリック医薬品の認証過程
    • 医療機器新製品の認証過程
    • 医薬品・医療機器の製造認可過程
    • 医薬品の輸出・輸入の認可
    • 知的所有権
    • 治験関連の規制
    • 医薬品の広告に関する規制
    • 薬局関連の規制
    • ラベリング・包装に関する規制

第5章 国の分析

  • 政治環境
  • 経済環境
  • 経済指標
  • 人口統計
  • 医療インフラ
    • 医療施設
    • 医療関連パラメーター
    • 環境問題
    • 医療従事者
  • 医療費支出
    • 概要
    • 医療費支出の主な要素
    • 公共/民間部門のシェア
    • 医薬品の研究開発(R&D)活動への支出額
  • 業界団体
  • 展示会

第6章 市場機会と課題

  • 市場機会
  • 課題

第7章 付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GDHC0081CHR

GlobalData, the industry analysis specialist, has released its latest report, "CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil". The report is an essential source of information on and analysis of the healthcare, regulatory and reimbursement landscape in Brazil. It identifies the key trends in the country's healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData's team of industry experts.

Brazil's population in 2013 was approximately 198 million, having grown at a Compound Annual Growth Rate (CAGR) of 0.9% from 2008. The country's increasingly elderly population and the corresponding increase in the incidence of chronic diseases will help to boost the growth of the pharmaceutical market, which was estimated to be worth $14.1 billion in 2008, and is projected to reach approximately $47.9 billion by 2020 at a CAGR of 8.5%. Approximately 60-80% of the Brazilian population has healthcare coverage, which has helped to create one of the most efficient healthcare systems among the BRICS countries, along with the fact that the government has taken new initiatives to promote generic drugs. The medical device market was valued at $6.4 billion in 2008, and is projected to grow at a CAGR of 7.5% to an estimated $14.2 billion in 2020, primarily attributed to -

  • Sedentary lifestyles leading to a high chronic disease burden
  • Easy accessibility to diagnostic technologies
  • Increased accessibility to healthcare professionals in remote areas

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Brazil, and includes -

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market: Hypermarcus, Pfizer, Novartis, Roche and EMS Sigma Pharma; and profiles and SWOT analyses of the major players in the medical device market: Siemens Healthcare, GE Healthcare, Roche, Essilor, and Philips
  • Insightful review of the reimbursement and regulatory landscape, with analysis covering details of the country's healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
  • Detailed analysis of the political and economic environment, covering economic indicators, demographics, healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities for and challenges to growth in the healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -

  • Develop business strategies by understanding the trends shaping and driving Brazil's healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to affect Brazil's healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for consolidation, investment, and strategic partnerships
  • Identify, understand, and capitalize on the opportunities and challenges in Brazil's healthcare market

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. GlobalData Report Guidance

3. Overview of Pharmaceutical and Medical Device Markets

  • 3.1. Pharmaceutical Market
    • 3.1.1. Market Overview
    • 3.1.2. Pharmaceutical Exports and Imports
    • 3.1.3. Supply Channels
    • 3.1.4. Market Segments
    • 3.1.5. Overview of Top Five Disease Areas
    • 3.1.6. Major Players
  • 3.2. Medical Device Market
    • 3.2.1. Market Overview
    • 3.2.2. Overview of Top Five Segments
    • 3.2.3. Diagnostic Market
    • 3.2.4. Major Players
  • 3.3. Market Drivers and Barriers
    • 3.3.1. Drivers
    • 3.3.2. Barriers

4. Market Access

  • 4.1. Overview of the Healthcare System
  • 4.2. Reimbursement and Payer Landscape
    • 4.2.1. Reimbursement Process
    • 4.2.2. Overview of Insurance Providers
    • 4.2.3. Patient Share in Healthcare Spending
    • 4.2.4. Prescription Drug Price Trend
    • 4.2.5. Pricing Policies
  • 4.3. Regulatory Landscape
    • 4.3.1. Overview of Regulatory Agencies
    • 4.3.2. Market Authorization Procedure for Pharmaceutical Products
    • 4.3.3. Market Authorization Procedure for Medical Devices
    • 4.3.4. Licensing Process for Pharmaceutical and Medical Device Manufacturing
    • 4.3.5. Licensing Process for Pharmaceutical Exports and Imports
    • 4.3.6. Intellectual Property Rights
    • 4.3.7. Clinical Trial Regulations
    • 4.3.8. Pharmaceutical Advertising Regulations
    • 4.3.9. Pharmacy Regulations
    • 4.3.10. Labeling and Packaging Regulations

5. Country Analysis

  • 5.1. Political Environment
    • 5.1.1. Political Structure
    • 5.1.2. Analysis of the Current Political Environment
    • 5.1.3. Healthcare Policy Initiatives
  • 5.2. Economic Landscape
  • 5.3. Economic Indicators
    • 5.3.1. Gross Domestic Product
    • 5.3.2. Gross National Income
    • 5.3.3. Inflation
    • 5.3.4. Currency Exchange Rate
    • 5.3.5. Foreign Direct Investment
    • 5.3.6. Foreign Exchange Reserves
    • 5.3.7. Trade Balance
    • 5.3.8. General Government Structural Balance
    • 5.3.9. General Government Net Debt
    • 5.3.10. Major Industries
  • 5.4. Demographics
    • 5.4.1. Population
    • 5.4.2. Education and Literacy Rate
    • 5.4.3. Employment
    • 5.4.4. Disease Burden
  • 5.5. Healthcare Infrastructure
    • 5.5.2. Healthcare Facilities
    • 5.5.3. Healthcare Parameters
    • 5.5.4. Environmental Health
    • 5.5.5. Healthcare Personnel
  • 5.6. Healthcare Expenditure
    • 5.6.1. Overview
    • 5.6.2. Major Components of Healthcare Spending
    • 5.6.3. Public and Private Sector Share
    • 5.6.4. Spending in Pharmaceutical Research and Development
  • 5.7. Trade Associations
    • 5.7.1. ABIMO
    • 5.7.2. ABIMED
    • 5.7.3. Interfarma
    • 5.7.4. Abiquifi
  • 5.8. Trade Fairs

6. Opportunities and Challenges

  • 6.1. Opportunities
  • 6.2. Challenges

7. Appendix

  • 7.1. Abbreviations
  • 7.2. Bibliography
  • 7.3. Research Methodology
    • 7.3.1. Coverage
    • 7.3.2. Secondary Research
    • 7.3.3. Forecasts
    • 7.3.4. Expert Panel
  • 7.4. Disclaimer

List of Tables

  • Table 1: Pharmaceutical Market, Brazil, Revenue ($bn), 2008-2013
  • Table 2: Pharmaceutical Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Table 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2008-2013
  • Table 4: Pharmaceutical Market, Brazil, Generic Drug Sales ($bn), 2008-2013
  • Table 5: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2013
  • Table 6: Pharmaceutical Market, Pfizer, Global, Major Products, 2014
  • Table 7: Pharmaceutical Market, Pfizer, Global, Late-Stage Pipeline, 2015
  • Table 8: Pharmaceutical Market, Novartis, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2014
  • Table 9: Pharmaceutical Market, Novartis, Global, Planned Filings, 2014-2019
  • Table 10: Pharmaceutical Market, Roche, Global, Major Products, Revenue ($bn) and Annual Growth (%), 2014
  • Table 11: Pharmaceutical Market, Roche, Global, Late-Stage Pipeline, 2015
  • Table 12: Medical Device Market, Brazil, Revenue ($bn), 2008-2013
  • Table 13: Medical Device Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Table 14: Medical Device Market, Brazil, Revenue by Segment, 2013
  • Table 15: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2008-2013
  • Table 16: Medical Device Market, Brazil, Ophthalmic Devices Market, Sales Trends for Major Players, 2012
  • Table 17: Medical Device Market, Brazil, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013
  • Table 18: Medical Device Market, Brazil, In Vitro Diagnostics Market, Sales Trends for Major Players, 2012
  • Table 19: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2008-2013
  • Table 20: Medical Device Market, Brazil, Orthopedic Devices Market, Sales Trends for Major Players, 2012
  • Table 21: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2008-2013
  • Table 22: Medical Device Market, Brazil, Diagnostic Imaging Market, Sales Trends for Major Players, 2012
  • Table 23: Medical Device Market, Brazil, Cardiovascular Device Market, Revenue ($bn), 2008-2013
  • Table 24: Medical Device Market, Brazil, Cardiovascular Device Market, Sales Trends for Major Players, 2012
  • Table 25: Medical Device Market, Brazil, Diagnostic Market, Revenue ($bn), 2008-2013
  • Table 26: Medical Device Market, Brazil, Diagnostic Market, Revenue Forecast ($bn), 2014-2020
  • Table 27: Medical Device Market, Brazil, Major Medical Device Companies, Revenue, 2012
  • Table 28: Healthcare System, Brazil, 2014
  • Table 29: Market Access, Brazil, Number of Items Listed in RENAME, 2013-2014
  • Table 30: Healthcare Spending, Brazil, Private Health Plans (million), 2008-2013
  • Table 31: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2008-2013
  • Table 32: Market Access, Brazil, Price Change (%), 2008-2013
  • Table 33: Pricing Policies, Brazil, 2014
  • Table 34: Market Access, Brazil, Compensation Services for Patents ($), 2014
  • Table 35: Market Access, Brazil, Compensation Services for Trademarks ($), 2014
  • Table 36: Healthcare System, Brazil, Documents Required for Dossier Submission of Clinical Trial, 2014
  • Table 37: Economic Indicators, Brazil, GDP per Capita ($), 2008-2013
  • Table 38: Economic Indicators, Brazil, GDP per Capita Forecast ($), 2014-2020
  • Table 39: Economic Indicators, Brazil, GDP Annual Growth (%), 2008-2013
  • Table 40: Economic Indicators, Brazil, GDP Annual Growth Forecast (%), 2014-2020
  • Table 41: Economic Indicators, Brazil, Gross National Income per Capita ($), 2008-2013
  • Table 42: Economic Indicators, Brazil, Average Consumer Price Index, 2008-2013
  • Table 43: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2008-2013
  • Table 44: Economic Indicators, Brazil, Currency Exchange Rate (BRL/$), 2008-2013
  • Table 45: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2008-2013
  • Table 46: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2008-2013
  • Table 47: Economic Indicators, Brazil, Trade balance ($bn), 2008-2013
  • Table 48: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2008-2013
  • Table 49: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2008-2013
  • Table 50: Economic Indicators, Brazil, Government Structural Balance ($bn), 2008-2013
  • Table 51: Economic Indicators, Brazil, General Government Net Debt ($bn), 2008-2013
  • Table 52: Economic Indicators, Brazil, Major Industries (Production Index), 2014
  • Table 53: Demographics, Brazil, Population (million), 2008-2013
  • Table 54: Demographics, Brazil, Population Forecast (million), 2014-2020
  • Table 55: Demographics, Brazil, Population, Urban and Rural Population (%), 2008-2013
  • Table 56: Demographics, Brazil, Population Distribution by Age Group (%), 2008-2013
  • Table 57: Demographics, Brazil, Population Distribution by Age Group Forecast (%), 2014-2020
  • Table 58: Demographics, Brazil, Births (per 1,000 population), 2008-2013
  • Table 59: Demographics, Brazil, Mortality (per 1,000 population), 2008-2013
  • Table 60: Demographics, Brazil, Major Causes of Mortality (per 1,000 population), 2013
  • Table 61: Demographics, Brazil, Children ≥5 Years, Mortality (per 1,000 Live Births), 2008-2013
  • Table 62: Demographics, Brazil, Immunization Rate (%), 2008-2013
  • Table 63: Demographics, Brazil, Major Causes of Male Mortality (per 1,000 population), 2013
  • Table 64: Demographics, Brazil, Major Causes of Female Mortality (per 1,000 population), 2013
  • Table 65: Demographics, Brazil, Gender Ratio (Male/Female), 2008-2013
  • Table 66: Demographics, Brazil, Life Expectancy at Birth (Years), 2008-2013
  • Table 67: Demographics, Brazil, Literacy Rate (%), 2008-2013
  • Table 68: Demographics, Brazil, Employment Rate (%), 2008-2013
  • Table 69: Demographics, Brazil, Major Diseases, DALYs (per 100,000 population), 2004
  • Table 70: Healthcare Infrastructure, Brazil, Type of Hospital (%), 2015
  • Table 71: Healthcare Infrastructure, Hospital Beds by Type of Service, Brazil, 2008-2013
  • Table 72: Healthcare Infrastructure, Hospital beds by Type of Care, Brazil, 2015
  • Table 73: Healthcare Infrastructure, Brazil, Diagnostic Equipment, 2015
  • Table 74: Healthcare Infrastructure, Brazil, Hospital Beds (per 1,000 population), 2008-2013
  • Table 75: Healthcare Infrastructure, Brazil, Doctors (per 1,000 population), 2008-2013
  • Table 76: Healthcare Infrastructure, Brazil, CO2 Emissions (Metric Tons per Capita), 2008-2013
  • Table 77: Healthcare Infrastructure, Brazil, N2O Emissions (Million Metric Tons), 2008-2013
  • Table 78: Healthcare Infrastructure, Brazil, PM10 Emissions (µg/m3), 2008-2013
  • Table 79: Healthcare Infrastructure, Brazil, Nurses (per 1,000 population), 2008-2013
  • Table 80: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2008-2013
  • Table 81: Healthcare Expenditure, Brazil, Share of Major Components (%), 2009
  • Table 82: Healthcare Expenditure, Brazil, Healthcare Expenditure, Public-Private Share (%), 2008-2013
  • Table 83: Healthcare Expenditure, Brazil, Research and Development Expenditure, Share (%), 2008
  • Table 84: Trade Fairs, Brazil, Major Healthcare Trade Fairs, 2015

List of Figures

  • Figure 1: Pharmaceutical Market, Brazil, Revenue ($bn), 2008-2013
  • Figure 2: Pharmaceutical Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Figure 3: Pharmaceutical Market, Brazil, Exports and Imports ($bn), 2008-2013
  • Figure 4: Pharmaceutical Distribution Channels, Brazil, 2011
  • Figure 5: Pharmaceutical Market, Brazil, Generic Drug Sales ($bn), 2008-2013
  • Figure 6: Pharmaceutical Market, Brazil, Mortality by Major Disease Areas (%), 2013
  • Figure 7: Medical Device Market, Brazil, Revenue ($bn), 2008-2013
  • Figure 8: Medical Device Market, Brazil, Revenue Forecast ($bn), 2014-2020
  • Figure 9: Medical Device Market, Brazil, Revenue by Segment ($bn), 2013
  • Figure 10: Medical Device Market, Brazil, Ophthalmic Devices Market, Revenue ($bn), 2008-2013
  • Figure 11: Medical Device Market, Brazil, Ophthalmic Devices Market, Sales Trends for Major Players, 2008-2012
  • Figure 12: Medical Device Market, Brazil, In Vitro Diagnostics Market, Revenue ($bn), 2008-2013
  • Figure 13: Medical Device Market, Brazil, In Vitro Diagnostics Market, Sales Trends for Major Players, 2008-2012
  • Figure 14: Medical Device Market, Brazil, Orthopedic Devices Market, Revenue ($bn), 2008-2013
  • Figure 15: Medical Device Market, Brazil, Orthopedic Devices Market, Sales Trends for Major Players, 2008-2012
  • Figure 16: Medical Device Market, Brazil, Diagnostic Imaging Market, Revenue ($bn), 2008-2013
  • Figure 17: Medical Device Market, Brazil, Diagnostic Imaging Market, Sales Trends for Major Players, 2008-2012
  • Figure 18: Medical Device Market, Brazil, Cardiovascular Device Market, Revenue ($bn), 2008-2013
  • Figure 19: Medical Device Market, Brazil, Cardiovascular Device Market, Sales Trends for Major Players, 2008-2012
  • Figure 20: Medical Device Market, Brazil, Diagnostic Market, Revenue ($bn), 2008-2013
  • Figure 21: Medical Device Market, Brazil, Diagnostic Market, Revenue Forecast ($bn), 2014-2020
  • Figure 22: Medical Device Market, Brazil, Major Medical Device Companies, Revenue ($m), 2012
  • Figure 23: Healthcare Market, Brazil, Drivers and Barriers, 2014
  • Figure 24: Healthcare System, Brazil, Reimbursement System, 2014
  • Figure 25: Healthcare System, Brazil, Reimbursement Process, 2014
  • Figure 26: Healthcare Spending, Brazil, Health Insurance Providers, 2014
  • Figure 27: Healthcare System, Brazil, Organization Structure of ANS, 2014
  • Figure 28: Healthcare Spending, Brazil, Private Health Plans (million), 2008-2013
  • Figure 29: Healthcare Spending, Brazil, Out-of-Pocket Expenditure (%), 2008-2013
  • Figure 30: Market Access, Brazil, Price Change (%), 2008-2013
  • Figure 31: Healthcare System, Brazil, Flowchart for Classification of Drugs into Categories, 2014
  • Figure 32: Market Access, Brazil, Ministry of Health Structure, 2014
  • Figure 33: Market Access, Brazil, Drug Approval Process, 2014
  • Figure 34: Economic Indicators, Brazil, GDP per Capita ($), 2008-2013
  • Figure 35: Economic Indicators, Brazil, GDP per Capita Forecast ($), 2014-2020
  • Figure 36: Economic Indicators, Brazil, GDP Annual Growth (%), 2008-2013
  • Figure 37: Economic Indicators, Brazil, GDP Annual Growth Forecast (%), 2014-2020
  • Figure 38: Economic Indicators, Brazil, Gross National Income per Capita ($), 2008-2013
  • Figure 39: Economic Indicators, Brazil, Average Consumer Price Index, 2008-2013
  • Figure 40: Economic Indicators, Brazil, Average Consumer Price Annual Change (%), 2008-2013
  • Figure 41: Economic Indicators, Brazil, Currency Exchange Rate (BRL/$), 2008-2013
  • Figure 42: Economic Indicators, Brazil, Foreign Direct Investment ($bn), 2008-2013
  • Figure 43: Economic Indicators, Brazil, Foreign Exchange Reserves ($bn), 2008-2013
  • Figure 44: Economic Indicators, Brazil, Trade Balance ($bn), 2008-2013
  • Figure 45: Economic Indicators, Brazil, Imports of Goods and Services ($bn), 2008-2013
  • Figure 46: Economic Indicators, Brazil, Exports of Goods and Services ($bn), 2008-2013
  • Figure 47: Economic Indicators, Brazil, Government Structural Balance ($bn), 2008-2013
  • Figure 48: Economic Indicators, Brazil, General Government Net Debt ($bn), 2008-2013
  • Figure 49: Economic Indicators, Brazil, Major Industries (Production Index), 2014
  • Figure 50: Demographics, Brazil, Population (million), 2008-2013
  • Figure 51: Demographics, Brazil, Population Forecast (million), 2014-2020
  • Figure 52: Demographics, Brazil, Population, Urban and Rural Population (%), 2008-2013
  • Figure 53: Demographics, Brazil, Population Distribution by Age Group (%), 2008-2013
  • Figure 54: Demographics, Brazil, Population Distribution by Age Group Forecast (%), 2014-2020
  • Figure 55: Demographics, Brazil, Births (per 1,000 population), 2008-2013
  • Figure 56: Demographics, Brazil, Mortality (per 1,000 population), 2008-2013
  • Figure 57: Demographics, Brazil, Major Causes of Mortality (per 1,000 population), 2013
  • Figure 58: Demographics, Brazil, Children ≥5 Years, Mortality (per 1,000 Live Births), 2008-2013
  • Figure 59: Demographics, Brazil, Immunization Rate (%), 2008-2013
  • Figure 60: Demographics, Brazil, Major Causes of Male Mortality (per 1,000 population), 2013
  • Figure 61: Demographics, Brazil, Major Causes of Female Mortality (per 1,000 population), 2013
  • Figure 62: Demographics, Brazil, Gender Ratio (Male/Female), 2008-2013
  • Figure 63: Demographics, Brazil, Life Expectancy at Birth (Years), 2008-2013
  • Figure 64: Demographics, Brazil, Literacy Rate (%), 2008-2013
  • Figure 65: Demographics, Brazil, Employment Rate (%), 2008-2013
  • Figure 66: Demographics, Brazil, Major Diseases, DALYs (per 100,000 population), 2004
  • Figure 67: Healthcare Infrastructure, Brazil, Type of Hospital (%), 2015
  • Figure 68: Healthcare Infrastructure, Hospital Beds by Type of Service, Brazil, 2008-2013
  • Figure 69: Healthcare Infrastructure, Hospital Beds by Type of Care, Brazil, 2015
  • Figure 70: Healthcare Infrastructure, Brazil, Diagnostic Equipment, 2015
  • Figure 71: Healthcare Infrastructure, Brazil, Total Hospital Beds (per 1,000 population), 2008-2013
  • Figure 72: Healthcare Infrastructure, Brazil, Doctors (per 1,000 population), 2008-2013
  • Figure 73: Healthcare Infrastructure, Brazil, CO2 Emissions (Metric Tons per Capita), 2008-2013
  • Figure 74: Healthcare Infrastructure, Brazil, N2O Emissions (Million Metric Tons), 2008-2013
  • Figure 75: Healthcare Infrastructure, Brazil, PM10 Emissions (µg/m3), 2008-2013
  • Figure 76: Healthcare Infrastructure, Brazil, Nurses (per 1,000 population), 2008-2013
  • Figure 77: Healthcare Expenditure, Brazil, Healthcare Expenditure (% of GDP), 2008-2013
  • Figure 78: Healthcare Expenditure, Brazil, Share of Major Components (%), 2012
  • Figure 79: Healthcare Expenditure, Brazil, Public-Private Share (%), 2008-2013
  • Figure 80: Healthcare Expenditure, Brazil, Research and Development Expenditure, Share (%), 2008
  • Figure 81: Healthcare Market, Brazil, Opportunities and Challenges, 2014
Back to Top